Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

COMMUNITY CARE MD PC

UEI: YE62XMB1CAY7

COMMUNITY CARE MD PC is a federal contractor, registered under UEI YE62XMB1CAY7. It has been awarded $90,042 across 5 federal contracts. Primary work spans Freestanding Ambulatory Surgical and Emergency Centers, Pharmaceutical Preparation Manufacturing, and Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

YE62XMB1CAY7

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Veterans Affairs$90.0K100%

Awards by NAICS

621493 - Freestanding Ambulatory Surgical and Emergency Centers$24.9K27.7%

325412 - Pharmaceutical Preparation Manufacturing$24.3K27%

423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers$21.6K24%

424210 - Drugs and Druggists' Sundries Merchant Wholesalers$19.2K21.4%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in COMMUNITY CARE MD PC's top NAICS codes and agencies

ENROFLOXACIN INJECT

Solicitation # SPE2DP-26-T-4496

Enrofloxacin Injection, a veterinary antibiotic solution for dogs, is supplied at a concentration of 2.27% with a dosage of 2.5 mg per kilogram in a 20 mL volume, intended for intramuscular use in managing bacterial pathogens. The product is regulated by the FDA and requires strict adherence to shelf-life requirements, with a non-extendable shelf life of 24 months classified as a Type I (Code M) item. Storage must be maintained at or below 25 degrees Celsius with excursions permitted up to 40 degrees Celsius, and the product must be protected from direct sunlight and freezing. Packaging and marking must conform to the latest edition of the Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and all units must be sealed in commercial containers designed to prevent damage and ensure safe transport. The item is procured under contract SPE2DP-26-T-4496 with a single unit of issue, delivered FOB destination within 81 days, with zero variance tolerance. Delivery is directed to the U.S. Medical Material Center in Kaiserslautern, Germany, with the required delivery date set for August 5, 2026. Supplier information includes Patterson Veterinary Supply, Inc. and Covetrus North America, LLC with designated part numbers, and all technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements. The contracting official must submit a referral via EBS for FDA-regulated product confirmation prior to award, including manufacturer and bidder details.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

NEOMYCIN AND POLYMYXIN

Solicitation # SPE2DP-26-T-4500

The contract covers the procurement of Neomycin and Polymyxin B Sulfates and Gramicidin, a regulated pharmaceutical product with NDC number 24208-0790-62, supplied by Bausch & Lomb Pharmaceuticals Division under the Veteran’s Health Joint Venture program. The item is classified as a TYPE I (CODE Q) with a strict non-extendable shelf life of 36 months, and all packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. Each unit must be sealed in a protective container and shipped in commercial exterior packaging suitable for safe transport by common carrier at the lowest cost to the delivery point, with all markings adhering to DLA’s medical marking standards. The product is subject to FDA regulation, requiring contracting officials to verify its status via EBS referral prior to award. The delivery is FOB destination, with required shipment within five days of award, and no quantity variance is permitted. The contract includes the NSN 6505-01-143-4643 and references the DLA Master List of Technical and Quality Requirements for applicable specifications, with the solicitation number SPE2DP-26-T-4500 and response deadline set for August 11, 2026. The item is procured under the authorized unit of issue BT (10 mL), with a total quantity of 3 units, and performance is to occur at Fort Lewis, WA. The contract is governed under federal acquisition protocols, and supplier submissions must include detailed information on the bidder, manufacturer, part number, and product description. All packaging and labeling must meet DLA’s technical and quality standards as defined in their official documentation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

BENZOCAINE ORAL TOPICA

Solicitation # SPE2DP-26-T-4499

BENZOCAINE ORAL TOPICAL GEL 20% in a 1 oz 28g unit is being procured under contract SPE2DP-26-T-4499 with a single unit of issue BT equivalent to 28 grams and a required delivery within 20 days FOB destination. The item is classified as a TYPE I medical product with a fixed 36-month non-extendable shelf life and must comply with all technical and quality specifications referenced in the DLA Master List of Technical and Quality Requirements. Packaging must meet commercial standards and adhere strictly to Medical Marking Standard No. 1 superseding MIL-STD-129, ensuring each unit is sealed in protective containment and shipped in appropriate exterior containers suitable for safe delivery via common carrier at the lowest cost. The product must be marked and documented in accordance with DLA medical standards and all applicable defense information security requirements. The manufacturer is BEUTLICH PHARMACEUTICALS LLC with NDC 00283-0871-31, and the NSN is 6505010645769 with zero variance allowed in quantity. Inspection and acceptance occur at the destination point, and the entire procurement is governed by DLA’s unit of issue guidelines as defined in their official documentation, with all packaging conforming to MIL-STD-2073-1E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

Solicitation # SPE2DH-26-T-5810

The contract is for the procurement of 2 packages of urinal bags, each containing 20 absorbent units designed to replace traditional plastic urinals by suppressing cleaning needs while still enabling accurate measurement of diuresis and laboratory analysis. These bags eliminate odors and are regulated by the FDA as a Class I medical device, requiring compliance with registration, listing, labeling, and GMP requirements, even though a 510(k) is not needed. The product must be marked according to the latest edition of the Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129, and packaging must follow DLA’s packaging requirements and MIL-STD-2073-1E standards. The unit of issue is a package (PG), with a total quantity of 2 packages ordered under purchase request 7017761630 at a total price of $2.00, with delivery required in 84 days, FOB destination. The item is identified by NSN 6530-01-608-6210 and manufacturer part number 939Y37373, supplied by Riverside Home Medical Supply Inc. All deliveries must be shipped to the designated address in Kaiserslautern, Germany, with the final destination being APO AE 09227-0000, and must be palletized and labeled in accordance with DLA standards. Transportation is governed by DLAD Procurement Notes C19 and C20, and the contract specifies zero variance in quantity. The contract number is SPE2DH-26-T-5810, issued by the Department of Defense’s Medical Supply Chain FSH, with a response deadline of August 12, 2026, and a required delivery date of August 5, 2026. Technical and quality requirements referenced by R or I numbers are governed by the DLA Master List, and the contract includes provisions for removal of government identification from non-accepted supplies. Covered defense information requirements may apply, and the contracting official must submit a referral to confirm regulatory compliance through EBS, including manufacturer and bidder details.

MEDICAL SUPPLY CHAIIN FSH

POSTED

about 5 hours ago

DEADLINE

PRAZIQUANTEL, PYRANT

Solicitation # SPE2DP-26-T-4495

This contract specifies the procurement of veterinary tablets containing 22.7 mg praziquantel, 22.7 mg pyrantel pamoate, and 113.4 mg febantel, intended for use in puppies or small dogs weighing at least 2 pounds and older than 3 weeks, to treat and control tapeworms, hookworms, and whipworms. The product is packaged in bottles of 50 tablets each, with a total of three bottles required under this solicitation. The item has a non-extendable shelf life of 36 months and must be stored at controlled room temperature. Packaging must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, superseding MIL-STD-129, with all units sealed and protected to prevent damage during transit. Delivery is required FOB destination within 81 days, to a specified military medical logistics center in Kaiserslautern, Germany, with the final destination being APO AE 09227-0000. The product is classified as hazardous material, requiring full compliance with OSHA’s Hazard Communication Standard, including the submission of Safety Data Sheets and compliant labels in accordance with 29 C.F.R. 1910.1200, along with employee training on these requirements. The procurement falls under NSN 6509-01-578-7110, with a unit price of $3.00 per bottle and a total contract value of $9.00. All supplies must be labeled and marked per government medical standards, and the supplier must adhere to the revised Federal Standard No. 313-E as of June 1, 2015, to ensure safety and regulatory compliance for government use.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

HealthPRO Canada RFP IPAC & Wound Care Contracts for Contracts Commencing June 1, 2027

Solicitation # June2027_RFPCL

HealthPRO Canada has issued a solicitation for contracts commencing June 1, 2027, targeting key products in infection prevention and wound care under solicitation number June2027_RFPCL. The RFP seeks suppliers for a range of medical products including surface disinfectants using citric and lactic acid in ready-to-use formulations, an electrical stimulation device to enhance venous blood flow, and multiple types of skin substitutes derived from biosynthetic, porcine, bovine, and cadaveric sources. Additional items include plant-based bio-cellulose dressings, transparent silicone film dressings, and a catalytic treatment matrix technology designed for wound and skin care applications. The solicitation is open to qualified vendors with responses due by September 16, 2026, and was posted on August 5, 2026. Contracts awarded through this process will serve Saskatchewan’s public sector healthcare system, with performance expected within the province. Primary inquiries should be directed to Christina Singh at rfpinquiries@healthprocanada.com, and further details are available through the Saskatchewan tenders portal.

POSTED

about 6 hours ago

DEADLINE

in about 1 month

Federal Occupational Health - Medications, Vaccines, and Medical Supplies (MVMS)

Solicitation # 7571MN26R00026

The U.S. Department of Health and Human Services, through its Federal Occupational Health (FOH) program and the Program Support Center, is seeking a contractor to provide a nationwide, web-based ordering portal for the procurement of medications, vaccines, and medical supplies (MVMS) to support over 300 federal entities and more than one million federal employees across the United States, the District of Columbia, and U.S. Territories. The contract is structured as a firm-fixed-price, indefinite-delivery/indefinite-quantity (IDIQ) award with a potential five-year performance period, consisting of a 12-month base period and four 12-month option periods, plus an optional six-month extension. The primary objective is to consolidate MVMS procurement into a single, efficient, and cost-effective system, eliminating reliance on government purchase cards and unstable supply chains while enhancing FOH’s oversight capabilities. The contractor will be responsible for maintaining a secure, user-accessible portal supporting up to 250 locations, ensuring just-in-time delivery with zero minimum order quantities, and strictly adhering to unit-dose or unit-of-use packaging requirements for all products as specified in Attachment J.1, with particular emphasis on readiness for critical items in Ready-to-Administer (RTA) format. All deliveries must comply with HHS digital accessibility standards, Section 508, CDC cold chain protocols, and federal, state, and local regulations, and must be marked with full consignee details, packing slips, and appropriate hazard or temperature-sensitive labels. Proposals must be submitted in four separate electronic volumes—Technical Proposal, Business/Cost Proposal, Past Performance, and a three-minute web portal demo—via email to Chaunda.Stewart@hhs.gov by the revised deadline of August 7, 2026, at 12:00 p.m. Eastern Time, following strict formatting requirements including a 25-page limit for the technical proposal, 12-point Times New Roman font, and 1-inch margins. All submissions must be accompanied by an Excel-based pricing worksheet detailing costs for each contract line item and the cumulative total. Offerors must pass four mandatory Phase One gate criteria: regulatory licensure including State Board of Pharmacy and FDA registrations, financial capability with a current ratio between 0.8 and 1.2, verified JIT logistics capability without minimum order thresholds, and 100% availability of unit-dose/RTA packaging for critical items. Those advancing to Phase Two will be scored

Program Support Center Acq Management Svc

POSTED

about 10 hours ago

DEADLINE

6505--Supplies - Radioactive Isotopes - Ann Arbor

Solicitation # 36C25026Q0724_1

The U.S. Department of Veterans Affairs through the 250-NETWORK Contract Office 10 is soliciting offers for the supply of radioactive isotopes to support medical services at the Ann Arbor VA and Toledo CBOC under a full and open competition. The solicitation, numbered 36C25026Q0724_1, was posted on August 5, 2026, with proposals due by 3:00 p.m. Eastern Time on August 13, 2026. The contract falls under NAICS code 325412, which pertains to the manufacturing of radioactive radioisotopes, and is being procured through a combined solicitation requiring qualified vendors to respond with competitive pricing, technical compliance, and adherence to all regulatory and safety standards for handling and delivering radioactive materials. The contracting officer is Kellie Konopinski, reachable via phone at 734-222-4330 or email at kellie.konopinski@va.gov, and all correspondence must be directed through this point of contact. The place of performance is not explicitly defined in the provided details, but the supplies are intended for use at the Ann Arbor VA and Toledo CBOC facilities. The contract office is located in Dayton, Ohio, with a ZIP code of 45428, and all responses must comply with federal procurement regulations. There is no set-aside designation for small businesses or other categories, indicating the opportunity is open to all eligible contractors. The RFQ requires detailed technical and commercial proposals, including documentation of regulatory certifications, quality assurance protocols, and logistics capabilities to ensure timely delivery of isotopes under strict radiological safety conditions. The full requirements, including isotopes specifications, delivery schedules, packaging standards, and reporting obligations, are detailed in the attached RFQ document.

250-NETWORK Contract Office 10 (36C250)

POSTED

about 10 hours ago

DEADLINE

ISOPROPYL ALCOHOL

Solicitation # SPE2DP-26-T-4494

ISOPROPYL ALCOHOL USP, commonly known as rubbing alcohol, is a 99% isopropanol solution supplied in 473-milliliter bottles, equivalent to one pint or 16 ounces, and is classified as an over-the-counter product regulated by the FDA. It is highly flammable, poses serious eye irritation risks, and may cause drowsiness or dizziness, requiring storage at 20° to 25°C (68° to 77°F) away from heat, sparks, open flames, and hot surfaces with strict no-smoking protocols. The item is identified by NSN 6505-00-205-6513 and must comply with applicable hazardous materials regulations including 49 CFR and ICAO technical instructions. A current Material Safety Data Sheet (MSDS) is mandatory and must accompany each shipment, submitted electronically to DLA.MSDS@DLA.MIL alongside the required cover sheet P-75. Packaging must meet hazardous materials standards, and government identification must be removed from non-accepted supplies. This procurement is governed by DLA’s Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date. The solicitation, issued under SPE2DP-26-T-4494 on August 4, 2026, with a response deadline of August 10, 2026, is for four bottles with a required delivery within five days to Pascagoula, Mississippi, under the NAICS code 325412, managed by the Department of Defense’s Medical Supply Chain Pharma FSA. All bidders must provide manufacturer details, part numbers, and item descriptions for FDA referral via EBS.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE AND EPINEP

Solicitation # SPE2DP-26-T-4478

The contract specifies the procurement of Bupivacaine and Epinephrine Injection, containing 0.500% w/v Bupivacaine HCl and 0.005 mg Epinephrine per mL (1:200,000), packaged in 1.8 mL cartridges, with a unit of issue of one case containing 50 cartridges. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and must have a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an 18-month maximum shelf life. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be commercially packaged to ensure safe transit under ASTM D3951 or applicable hazardous material standards if classified as hazardous under FED-STD-313. The supply must be free of intentional mercury or mercury compounds, except where functionally necessary and explicitly exempted, and any permitted mercury-containing components must meet Navy shockproof and secondary containment requirements. Delivery is required FOB destination within 20 days to the USS Delaware (SSN 791) at FPO AE 09583, with no variance allowed in quantity, and shipment must use traceable, expedited methods with no parcel post. The item is identified by NSN 6505-01-189-3973 and purchase request 7017729383, with a required delivery date of August 6, 2026. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, which supersedes any conflicting standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VERAPAMIL HYDROCHLO

Solicitation # SPE2DP-26-T-4480

Verapamil Hydrochloride Extended-Release Tablets, 240 mg, are being procured in bottles of 100 tablets each, with a total quantity of two bottles required under contract SPE2DP-26-T-4480. The product must have a minimum of 31 months of shelf life remaining at the time of delivery, with a full 36-month shelf life specified and non-extendable. Packaging must comply strictly with DLA Packaging Requirements for Procurement and the latest Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection from damage during transit. All units must be commercially packaged in suitable exterior shipping containers, meeting the lowest freight rate standard for delivery to the specified destination. The item is regulated by the FDA, and the contracting official must confirm compliance via EBS referral. Manufacturer and distributor information includes Glenmark Pharmaceuticals Inc., USA and Cardinal Health 200, LLC, with the NDC number NDC68462-0260-01. The delivery is FOB destination, with a 20-day delivery window and no quantity variance permitted. Shipment must be traceable and cannot be sent via parcel post; instead, it must be transported using the FASTEST TRACEABLE MEANS with RDD 777 and referenced to the DLA vendor code V23027. The required delivery date is February 17, 2026, and the item is to be delivered to USS IWO JIMA LHD 7, FPO AA 34094. All packaging, labeling, and documentation must adhere to applicable DLA technical and quality requirements listed in the DLA Master List, which take precedence over ASTM D3951 and other commercial standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4493

Carbon Dioxide, Technical, USP Cylinder Type E, is being procured in quantities of two units, each containing 6 pounds of gas at a minimum purity of 99.5 percent, pressurized to 1800 PSI, with a total filled weight of 20 pounds excluding the cap. The unit of issue is each (EA), and the material must conform to Medical Marking Standard No. 1, which replaces all references to MIL-STD-129; copies of this standard are available from DLA Troop Support via email or their official website. Each cylinder must be securely packaged in a sealed container to prevent damage or breakage, and shipped in commercially appropriate exterior containers that ensure safe delivery by common carrier at the lowest possible rate to the designated delivery point. Packaging requirements are governed by DLA Packaging Requirements for Procurement, and technical and quality specifications are referenced from the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on acquisition type. The item is identified by NSN 6505-01-212-7489 under Purchase Request 7017735431, with a delivery requirement of 20 days from award. Bidders must clearly state the source and part number being offered, and all supplies must comply with government guidelines for removal of identification from non-accepted items. The solicitation, issued under SPE2DP-26-T-4493 on August 4, 2026, with a response deadline of August 10, 2026, is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Shairy M. Cartagena as the primary point of contact.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BRUSH, SURGICAL SCRU

Solicitation # SPE2DH-26-T-5787

The contract specifies the procurement of 4 packages, each containing 300 disposable surgical scrub brushes, for a total of 1,200 units. Each package must consist of 10 dispensers, with each dispenser holding 30 brushes, and all packaging must comply with commercial standards and be sealed to protect against damage during transit. The product must have a minimum shelf life of 24 months, with no more than three months elapsed between the manufacturer’s date and delivery to the government. All labeling must include the date of manufacture, expiration or retest date, contract number, and lot number, following the latest revision of Medical Marking Standard No. 1, which replaces MIL-STD-129. The brushes are to be shipped in commercial exterior containers suitable for safe delivery via common carrier to Ellsworth AFB, South Dakota, with delivery required within 20 days of award. Suppliers must provide the source and part number for the product, and all items must conform to technical and quality requirements listed in the DLA Master List. The procurement is under solicitation SPE2DH-26-T-5787, with responses due by August 11, 2026, and is managed by the Department of Defense’s Medical Supply Chain FSH.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

ALBUTEROL INHALATIO

Solicitation # SPE2DP-26-T-4470

Albuterol Inhalation Aerosol is a prescription-only medication supplied as a pressurized aluminum canister containing 60 actuations, each delivering 108 micrograms of albuterol sulfate, equivalent to 90 micrograms of albuterol base, through a plastic actuator with a strap cap and built-in counter. The canister has a net weight of 8 grams and must be stored at 20° to 25°C (68° to 77°F), with allowable excursions between 15° and 30°C, following USP controlled room temperature guidelines. The inhaler must be kept with the mouthpiece down, shaken well before each use, and brought to room temperature prior to administration to ensure optimal performance. The product has a non-extendable shelf life of 18 months, and at the time of receipt by the first government activity, a minimum of 15 months of shelf life must remain. It is labeled and marked in compliance with SPE2DP-26-T-4470 and Medical Marking Standard No. 1C, and is classified as a hazardous material with flammable characteristics due to its pressurized contents. The canister must not be punctured, exposed to temperatures above 120°F, or disposed of in fire or incinerators. A current Material Safety Data Sheet (MSDS) is required and must accompany each shipment, submitted electronically to DLA.MSDS@DLA.MIL along with a completed cover sheet. Packaging must conform to 49 CFR and ICAO regulations for hazardous materials. The NSN is 6505-01-649-7928, with a quantity of 15 units ordered under Purchase Request 7017715897, with delivery required within 20 days of award. The solicitation is governed by DLA technical and quality requirements referenced in the DLA Master List, and buyers must confirm regulatory compliance through an EBS referral to the product specialist, providing manufacturer and bidder details. The item is regulated by the FDA and falls under Defense Information potentially subject to additional reporting.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-26-T-4477

Permectrin Cream Rinse is a 1% w/v topical medication packaged as a 2 fl oz plastic squeeze bottle, each unit including a comb for application, and supplied in individual units with a minimum of 21 months of remaining shelf life at time of receipt by the government, ensuring a 24-month total shelf life is maintained. The item is regulated by the FDA and must comply with all applicable medical, packaging, and hazardous materials standards including Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging requirements that ensure protection from damage during shipping and compliance with commercial standards for both interior and exterior containers. All shipments must include a current Safety Data Sheet (SDS) formatted per 29 C.F.R. 1910.1200, with labels meeting OSHA’s Hazard Communication Standard and the Globally Harmonized System, and these documents must be submitted for approval before contract award. Each shipment must also carry a copy of the SDS and be marked in accordance with the approved medical marking guidelines. The product is subject to DLA’s technical and quality requirements as outlined in the DLA Master List, and must comply with all applicable transportation regulations including 49 CFR and ICAO standards for hazardous materials. The NSN is 6505-01-256-4972, with two units requested under solicitation SPE2DP-26-T-4477, with a 20-day delivery requirement and a contract awarded to a government activity under the Department of Defense.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM PERBORATE

Solicitation # SPE2DP-26-T-4492

Sodium perborate in powder form, packaged in 100-gram bottles, is procured under contract SPE2DP-26-T-4492 for delivery to USS PORTLAND LPD 27 in San Diego, California. The item has a strict 36-month shelf life that is non-extendable and must be stored away from high humidity and temperatures exceeding 32 degrees Celsius, with separation from flammable materials. It is subject to defense information protections and incorporates technical and quality requirements from the DLA Master List, which supersede commercial standards. Packaging must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and adhere to DLA packaging specifications including palletization and hazardous material handling if applicable. The item is regulated by the FDA, requiring referral through EBS for product specialist confirmation. Delivery is FOB destination within 20 days, with no tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The sole unit of issue is the bottle (BT), with one bottle ordered, and the NSN is 6505-01-307-3268. The contract identifies approved suppliers including Sultan Chemists Inc, Henry Schein Inc, and Patterson Dental Supply, with specific part numbers. Transportation procedures follow DLA directives, and the shipment must be labeled with the provided TCN and reference codes. The original required delivery date is August 6, 2026, with a response deadline of August 10, 2026 for the solicitation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CLINDAMYCIN PHOSPHA

Solicitation # SPE2DP-26-T-4488

CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION, USP, is being procured under contract SPE2DP-26-T4488 with a quantity of 4 bottles, each containing 60 mL, identified by NSN 6505-01-116-5655 and NDC codes including PHARMACIA/UPJOHN 00009-3116-02 and FOUGERA 00168-0201-60. The product must be stored at controlled room temperature and protected from freezing. Packaging requirements mandate commercial standard unit containers that safeguard against damage or breakage, packed in suitable exterior shipping containers compliant with carrier requirements for safe, cost-effective delivery to the specified point. All labeling must adhere to Medical Marking Standard No. 1, replacing MIL-STD-129, and copies of this standard are available via DLA Troop Support. The solution is subject to hazardous materials regulations, requiring a current Material Safety Data Sheet to accompany each shipment and be submitted electronically to DLA.MSDS@DLA.MIL with the required cover sheet. Mercury and mercury-containing compounds are strictly prohibited in the product or its packaging except for limited, specified exemptions. The item is not TAA compliant under the Greenstone NDC code. Technical and quality requirements are governed by the DLA Master List, with revisions effective as of the solicitation date. Delivery is due within 10 days of award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJ

Solicitation # SPE2DP-26-T-4367

Sodium Chloride 0.9% Injection, USP, 500 mL, 24 units per pack, is being procured under solicitation SPE2DP-26-T-4367 for delivery to the USS NEW ORLEANS LPD 18 at FPO AP 96673, with a required delivery window of 20 days after order placement and FOB Destination terms. The contract specifies a quantity of 10 packing groups, each containing 24 units, and mandates strict adherence to medical packaging and labeling standards, superseding MIL-STD-129 with Medical Marking Standard No. 1. The product is regulated by the FDA, and the contracting official must refer bidders through EBS for product specialist confirmation, including manufacturer details and NDC numbers. Packaging must be commercial and compliant with ASTM D3951 for non-hazardous materials, but DLA’s Master List of Technical and Quality Requirements takes precedence. A 24-month non-extendable shelf life applies, and mercury or mercury-containing compounds are prohibited unless exempted for specific functional uses such as batteries or instruments, with additional containment requirements per NAVSEA 5100-003D. Hazardous material handling must follow FED-STD-313 and TQ Requirement IP025, with labeling per OSHA’s Hazard Communication Standard. The item is subject to DFARS clauses covering safeguarding covered defense information, prohibition of certain telecommunications equipment, whistleblower rights, and restrictions on toxic or hazardous materials. Offerors must provide UEI and CAGE codes, represent their small business status if applicable, and comply with trafficking in persons, employment eligibility verification, and sustainable product requirements. All submissions must be made through DIBBS by August 4, 2026, and the contract will be evaluated under likely Low Price Technically Acceptable criteria. Payment will be processed via WAWF, and inspection and acceptance occur at the delivery point. Multiple manufacturers are listed as qualified suppliers, including Baxter Healthcare, B. Braun Medical, Cardinal Health, McKesson, and ICU Medical, each identified by their part numbers and NDC codes.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE